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JNK2 and IKKb Are Required for Activating
the Innate Response to Viral Infection
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proteins following viral infection have yet to be eluci-and Michael Karin*§
dated (Juang et al., 1998; Wathelet et al., 1998; Yone-*Laboratory of Signal Transduction
yama et al., 1998). NF-kB and AP-1 are also involved inand Gene Regulation
the induction of proinflammatory and cytotoxic cyto-Department of Pharmacology
kines (Barnes and Karin, 1997; Ip and Davis, 1998).University of California, San Diego
NF-kB proteins are regulated through interaction withLa Jolla, California 92093-0636
specific inhibitors, the IkBs, which retain them in the²Department of Biology
cytoplasm of nonstimulated cells (Verma et al., 1995;Molecular Biology Institute
Baldwin 1996). In response to proinflammatory stimuliSan Diego State University
including viral infection, the IkBs undergo rapid phos-San Diego, California 92182
phorylation at conserved N-terminal sites that trigger³Department of Cancer Biology
their ubiquitin-dependent degradation and subsequentThe Lerner Research Institute
nuclear translocation of the liberated NF-kB dimers (Del-Cleveland, Ohio 44195
hase and Karin, 1999). The signal-responsive protein
kinase that phosphorylates the IkBs and thereby causes
NF-kB activation was molecularly identified (DiDonatoSummary
et al., 1997; Mercurio et al., 1997; ReÂ gnier et al., 1997).
This protein kinase, IKK, is composed of two catalyticViral infection or double-stranded (ds) RNA induce in-
subunits, IKKa and IKKb, and one regulatory subunit,terferons (IFN) and other cytokines. Transcription fac-
IKKg/NEMO (Zandi et al., 1997; 1998; Rothwarf et al.,tors mediating IFN induction are known, but the signal-
1998; Yamaoka et al., 1998; Delhase and Karin, 1999).ing pathways that regulate them are less clear. We
IKKg/NEMO is required for activation of NF-kB by manynow describe two such pathways. The first pathway
stimuli, including the proinflammatory cytokines tumorleading to NF-kB depends on the dsRNA-responsive
necrosis factor a (TNFa) and IL-1, bacterial lipopolysac-protein kinase (PKR), which in turn activates IkB ki-
charide (LPS), and dsRNA (Yamaoka et al., 1998). Sur-nase (IKK) through the IKKb subunit. The second viral-
prisingly, however, only the IKKb catalytic subunit isand dsRNA-responsive pathway is PKR independent
required for IKK and NF-kB activation by proinflamma-and involves Jun kinase (JNK) activation leading to
tory cytokines and LPS (Delhase et al., 1999; Li et al.,stimulation of AP-1. Both IKKb and JNK2 are essential
1999, 1999; Tanaka et al., 1999), whereas IKKa mediatesfor efficient induction of type I IFN and other cytokines
a response to a yet-to-be identified developmental sig-in response to viral infection or dsRNA. This study
nal that controls keratinocyte differentiation (Hu et al.,establishes a general role for these kinases in activa-
1999; Takeda et al., 1999). Which catalytic subunit medi-tion of innate immune responses.
ates the response to virus and dsRNA was heretofore
unknown.
Introduction Unlike NF-kB, c-Jun:ATF2 (and other AP-1) hetero-
dimers are constitutively nuclear, but their transactivat-
Viral infection of mammalian cells results in activation ing potential is rapidly stimulated by phosphorylation of
of an innate antiviral response mediated by type I inter- their activation domains (BineÂ truy et al., 1991; Smeal et
ferons (IFNs), which impair viral gene expression and al., 1991; Gupta et al., 1995) by the Jun kinases (JNKs,
replication (Sen and Lengyel, 1992; MuÈ ller et al., 1994), Hibi et al., 1993; DeÂ rijard et al., 1994; Kyriakis et al.,
as well as by other cytokines, such as interleukin (IL)-6 1994; Karin, 1995). As other MAP kinases (MAPKs), the
(Pulliam et al., 1995) and IL-12 (Orange and Biron, 1996), JNKs are activated via protein kinase cascades involv-
which activate cell-mediated cytotoxic responses. Reg- ing two JNK kinases (JNKKs) and a much larger number
ulation of IFN expression has been the subject of intense of upstream kinases (reviewed by Minden and Karin,
investigation, and several transcription factors and ar- 1997). Both JNK1 and JNK2 respond to T cell activators
chitectural proteins that bind IFN gene promoters were (Su et al., 1994) and are required for induction of T cell
identified (Reis et al., 1992; Du et al., 1993; Matsuyama cytokines (Dong et al., 1998; Yang et al., 1998; Sabapa-
et al., 1993; Thanos and Maniatis, 1995). One of these thy et al., 1999).
proteins, HMGI(Y), facilitates assembly of an enhanceo- The signaling pathways that are activated by viral in-
some that contains several signal-responsive transcrip- fection and lead to activation of NF-kB and c-Jun:ATF2
tion factors, including NF-kB (p50:p65), c-Jun:ATF2 (AP-1) are rather nebulous. In the case of NF-kB, a role in the
heterodimers, and members of the IRF family (Thanos viral response was ascribed to the dsRNA-dependent
and Maniatis, 1995; Wathelet et al., 1998). The control of kinase PKR (Kumar et al., 1994). PKR contains two RNA
NF-kB and c-Jun:ATF2 activities, in response to stimuli binding regulatory domains at its N terminus and a ser-
ine/threonine protein kinase domain at its C terminus
(reviewed by Clemens and Elia, 1997; Williams, 1997).§ To whom correspondence should be addressed (e-mail: karinoffice@
ucsd.edu). PKR expression is transcriptionally induced by IFNs,
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while its catalytic activity is stimulated by binding in either IKKa (Hu et al., 1999) or IKKb (Li et al., 1999). We
used primary embryonic fibroblasts (MEFs) from Ikka2/2dsRNAs, which are produced during viral infection. As
and Ikkb2/2 embryos to investigate the involvement ofmost cells express basal levels of PKR, its regulation
the two catalytic subunits in the response to dsRNAmay involve a feed-forward positive autoregulatory cas-
and virus. No substantial differences in IKK activationcade in which dsRNA produced during viral transcription
in response to either dsRNA (Figure 1C) or infectionor replication activates preexisting PKR, which then acti-
with vesicular stomatitis virus ([VSV]; Figure 1D) werevates transcription factors that lead to IFN induction.
detected between wt or IKKa-deficient MEFs. By con-Newly synthesized IFNs activate the JAK-STAT signal-
trast, loss of the IKKb subunit severely impaired IKKing cascade (Darnell et al., 1994; Ihle et al., 1994), re-
activation by either dsRNA (Figure 1E) or VSV (Figuresulting in induction of more PKR and other IFN-respon-
1F). As a result, very little NF-kB binding activity wassive gene products. This model is supported by analysis
induced by either dsRNA or VSV in IKKb-deficient cells.of PKR-deficient mice and cells (Yang et al., 1995; Kumar
As a negative control, we measured JNK activity in theet al., 1997). These studies also suggest that induction
different cells and much to our surprise found it to beof IRF-1 is dependent at least in part on NF-kB (Kumar
induced by both dsRNA and VSV (Figures 1C±1F). Theet al., 1997). Although it was suggested that PKR may
kinetics of JNK activation were a bit slower from thosedirectly phosphorylate IkBs (Kumar et al., 1994), NF-kB
of IKK but were not affected by the loss of either IKKais activated by TNFa in PKR-deficient cells (Yang et al.,
or IKKb. A similar, but even more robust, JNK activation1995; Kumar et al., 1997), whereas IKKg/NEMO-deficient
response was detected in HEK293 cells (data notcells do not respond to dsRNA (Yamaoka et al., 1998).
shown).However, it was also observed that PKR-deficient mice
Next, we examined the dependence of IKK activationand cells exhibit residual IFN induction responses to
on PKR, using two immortalized mouse fibroblast cellviral infection and dsRNA, thus suggesting the existence
lines derived from either wt (Pkr1/1) or PKR knockoutof additional, PKR-independent, signaling pathways
mice (Pkr2/2) (Yang et al., 1995; Kumar et al., 1997).(Yang et al., 1995). The signaling pathways that activate
While incubation of Pkr1/1 cells with dsRNA resulted inc-Jun:ATF2 and other forms of AP-1 in response to viral
IKK activation, there was no appreciable increase in IKKinfection are largely unknown.
activity during the first 4 hr of treatment with dsRNA inWe investigated signaling pathways responsive to vi-
Pkr2/2 cells (Figure 2A), but after 4 hr there was a smallral infection or dsRNA that can lead to induction of
but reproducible increase in IKK activity in Pkr2/2 cellstype I IFNs and other cytokines. We obtained evidence
(data not shown). Both cell lines, however, were respon-indicating that a major pathway that leads to NF-kB
sive to TNFa, an established IKK activator. It should beactivation is indeed dependent on PKR, but in this path-
noted that in mouse fibroblasts, unlike HEK293 cells, theway PKR acts upstream to IKK, targeting its IKKb sub-
response of IKK to dsRNA is weaker than its response tounit rather than IKKa. We demonstrate that IKKb is es-
TNFa (see also Figure 1E). As previously describedsential for induction of type I IFNs and other cytokines.
(Yang et al., 1995), Pkr2/2 cells exhibited a defective NF-We identified a second signaling pathway elicited by
kB activation response to dsRNA but a normal responseviral infection or dsRNA that leads to JNK activation.
to TNFa (Figure 2A). Surprisingly, incubation of bothThis pathway can enhance the transcriptional activity of
Pkr1/1 and Pkr2/2 cells with dsRNA resulted in efficientc-Jun:ATF2 and other AP-1 dimers, and its importance is
JNK activation that was similar in magnitude to the re-illustrated by JNK2-deficient cells, which exhibit a defect
sponse to TNFa, one of the most potent JNK activators.in induction of type I IFNs in response to viral infection
The defect in IKK activation by dsRNA was indeedor dsRNA.
caused by the absence of functional PKR, as coex-
pression of an epitope-tagged IKKb with wt PKR in
Results Pkr2/2 cells restored robust IKK activation by dsRNA
(Figure 2B).
PKR Acts Upstream to IKK Pkr2/2 cells also exhibited a defect in IKK and NF-
We established pools of HEK293 cells, stably expressing kB activation in response to VSV infection. While VSV
either wild-type (wt) or catalytically inactive [IKKa (KM) infection of wt fibroblasts resulted in IKK and NF-kB
and IKKb (KA)] epitope-tagged forms of IKKa and IKKb. activation within 3 hr, the response of Pkr2/2 fibroblasts
Stable transfection of either wt IKKa or wt IKKb did to VSV infection was considerably attenuated and de-
not considerably potentiate IKK or NF-kB activation by layed (Figure 2C). IKK and NF-kB activities were in-
either dsRNA or TNFa (Figure 1A). However, expression creased only after 7 hr post infection in Pkr2/2 cells, and
of IKKa (KM) resulted in a small decrease in IKK activity, even at that point both responses were weaker than
whereas the IKKb (KA) mutant almost completely abol- those in Pkr1/1 cells. These results were not due to
ished dsRNA or TNFa induced IKK activity and markedly differences in susceptibility of the two cell lines to VSV
reduced NF-kB activation. Although considerable IKK infection. For instance, the kinetics of viral RNA replica-
activation is observed after a 10 min incubation with tion, following infection at an moi of 10, determined by
dsRNA, kinase activity peaks only after 3 hr (Figure 1B). hybridization to the VSV L gene probe, were similar in
Therefore, the response to dsRNA is considerably the two cell lines (see below). In addition, VSV infection
slower than the response to TNFa, which peaks within of both Pkr1/1 and Pkr2/2 cells resulted in similar levels
15 to 20 min and decays within 30 to 60 min (Zandi et of JNK activation detected at 5±7 hr post infection (Fig-
al., 1997; Delhase et al., 1999). IKK activation is maximal ure 2C).
at 12.5 mg/ml of dsRNA. These experiments indicate that PKR acts upstream
to IKK in the response pathway elicited by either virusWe recently generated mutant mice that are deficient
JNK and IKK Required for Interferon Induction
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Figure 1. Involvement of IKK in NF-kB Acti-
vation by dsRNA and Virus
(A) Parental HEK293 cells and pools of
HEK293 cells stably transfected with either
wt or catalytically inactive IKK [IKKa (KM) and
IKKb (KA)] expression vectors were treated
with dsRNA (50 mg/ml) for 3 hr or TNFa (20 ng/
ml) for 10 min and then lysed. Lysates were
assayed for IKK kinase activity (KA) by an
immunecomplex kinase assay. Recovery of
IKK was determined by immunoblotting (IB)
with anti-IKKa antibody. NF-kB DNA binding
activity was measured by an electrophoretic
mobility shift assay (EMSA).
(B) IKK activity was measured at different
time points after treatment of HEK293 cells
with 50 mg/ml dsRNA (left panel) or at 3 hr
after treatment with different concentrations
of dsRNA (right panel). For comparison, cells
were treated with TNFa (20 ng/ml) for 10 min.
(C) MEFs derived from wt (Ikka1/1) and
Ikka2/2 embryos were treated or not with
dsRNA. At the indicated time points, cells
were lysed, IKK was isolated by IKKg antibod-
ies to measure IkB kinase activity (KA), and
JNK was isolated with anti-JNK1 antibodies
to measure c-Jun kinase activity. Recovery
of IKK and JNK was determined by immu-
noblotting (IB) with anti-IKKg and anti-JNK1,
respectively.
(D) Ikka1/1 and Ikka2/2 MEFs were infected
with VSV (moi 5 10), and at the indicated
times IKK and JNK activities were measured
as described above.
(E) MEFs derived from wt (Ikkb1/1) and Ikkb2/2
embryos were examined for activation of IKK,
NF-kB, and JNK by dsRNA as described
above.
(F) Ikkb1/1 and Ikkb2/2 MEFs were examined
for IKK, NF-kB, and JNK activation in re-
sponse to VSV infection (moi 5 10).
infection or dsRNA. However, residual and delayed IKK serines were replaced by alanines was no longer respon-
sive to either wt or catalytically inactive PKR, either inand NF-kB activation can occur in the absence of PKR.
Efficient IKK activation by VSV or dsRNA requires the vivo (Figure 3A) or in vitro (Figure 3B). Neither form of
PKR activated JNK1, JNK2 (Figure 3C), or p38 (data notIKKb catalytic subunit. On the other hand, PKR is not
involved to any extent in viral- or dsRNA-induced JNK shown). We also found that JNK activation by dsRNA
is inhibited in cells, which stably express inactive mu-activation.
tants of JNKK1 or JNKK2 (data not shown). We interpret
these results to suggest that PKR catalytic activity isDifferential Response of IKK and JNK to PKR
To further examine the relationships between PKR and mostly required for its autoactivation (Clemens and Elia
1997; Williams, 1997), and once sufficient amounts ofthe IKK and JNK activation cascades, we cotransfected
expression vectors encoding epitope-tagged IKKb, JNK1, PKR are present it may activate IKK by direct protein±
protein interaction.or JNK2 with either wt or catalytically inactive (a K296R
mutant) PKR expression vectors. Coexpression of HA-
IKKb with wt PKR resulted in efficient dose-dependent
IKK activation (Figure 3A). When expressed at low levels, JNK2 and IKKb Are Required for Optimal IFN
and Cytokine InductionPKR (K296R) led to poor IKK activation, but, surprisingly,
when expressed at higher levels PKR (K296R) activated To determine whether the newly discovered PKR-inde-
pendent dsRNA-responsive signaling pathway that leadsIKK. To examine this point further, we tested whether
recombinant wt PKR and PKR (K296R) purified from to JNK activation contributes to type I IFN gene induc-
tion, we used nonimmortalized (MEF) and immortalizedEscherichia coli can directly activate recombinant IKKb
purified from Sf9 cells. Although recombinant IKKb dis- (3T3) fibroblasts derived from wt, Jnk12/2, and Jnk22/2
E12 mouse embryos. We compared the induction ofplays considerable basal activity (Zandi et al., 1998), its
incubation with either wt PKR or PKR (K296R) further IFNa1 and IFNb mRNA in these cells to their induction
in Pkr2/2 fibroblasts and IKK-deficient cells. As pre-increased its IkB kinase activity (Figure 3B). This activa-
tion required phosphorylation at Ser-177 and Ser-181 viously described (Yang et al., 1995), little induction of
IFNa1 or IFNb mRNA was observed in Pkr2/2 fibroblasts(Delhase et al., 1999), because a mutant in which these
Immunity
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Figure 3. PKR Activates IKK but Not JNK
Figure 2. Role of PKR in IKK and JNK Activation by dsRNA or Virus (A) Wt 3T3 fibroblasts were transfected with HA-IKKb, HA-IKKb (AA),
(A) Immortalized fibroblasts (3T3) derived from wt (Pkr1/1) or Pkr2/2 or HA-IKKb (KA) expression vectors (200 ng/plate) along with wt
embryos (Kumar et al., 1997) were treated with dsRNA (100 mg/ml) PKR or catalytically inactive PKR (K296R) expression vectors (200
for the indicated periods or with TNFa for 10 min, after which IKK ng/plate in lanes 2 and 5, 400 ng/plate in lanes 3 and 6, or 800 ng/
and JNK activities were measured by immunecomplex kinase plate in lanes 4, 7, 10, and 13). Where indicated, instead of a PKR
assays (KA). Recoveries of IKK (IKKa) and JNK1 were determined expression vector, the cells were transfected with an empty expres-
by immunoblotting (IB). NF-kB and NF-1 DNA binding activities were sion vector (400±600 ng/plate, lanes 1, 5, 8, 9, 11, and 14) and
determined by EMSA. were either left untreated or treated with TNFa for 10 min prior to
(B) Exogenous PKR restores IKK activation in Pkr2/2 cells. Pkr2/2 harvesting. After 36 hr, the cells were lysed, HA-IKKb containing IKK
fibroblasts were cotransfected with an HA-IKKb expression vector complexes were isolated by immunoprecipitation, and their kinase
along with either ªemptyº or PKR expression vectors. After 36 hr, activity and recoveries determined by immunecomplex kinase assay
the cells were treated with dsRNA, and HA-IKKb associated kinase (KA) and immunoblotting (IB), respectively.
activity and expression were determined as above. (B) In vitro activation. Wt IKKb (1 ng) or IKKb (AA) (10 ng) purified
(C) Pkr1/1 and Pkr2/2 cells were infected with VSV (moi 5 10). At from baculovirus infected Sf9 cells were incubated with either wt
the indicated times post infection, cell lysates were prepared and PKR or PKR (K296R) (12.5 ng in lanes 2 and 6; 25 ng in lanes 3, 7,
used to measure IKK and JNK activities and expression and NF-kB 11, and 13, or 50 ng in lanes 4, 5, 8, 9, 12, and 14) for 30 min, after
and NF-1 DNA binding activities. which the IkB kinase activities of the IKKb proteins were examined.
Wt PKR or PKR (K296R) were also tested directly for IkBa (1±54)
phosphorylation (lanes 5 and 9, respectively).upon treatment with dsRNA (Figure 4A). A similar reduc-
(C) Wt 3T3 cells were transfected with either HA-JNK1 or HA-JNK2
tion in IFN mRNA induction was observed in both nonim- expression vectors (0.5 mg/plate) along with empty expression vec-
mortalized and immortalized fibroblasts from Jnk22/2 tor or a PKR expression vector (0.4 mg/plate). Where indicated, cells
were treated with TNFa for 10 min before harvesting. After 24 hr,mice (Figure 4B). A more modest reduction in IFN mRNA
cell lysates were prepared and HA-JNK immunoprecipitated, andinduction was observed in Jnk12/2 fibroblasts (data not
their kinase activity and recoveries were determined by an im-shown). Consistent with the effects on IKK activation
munecomplex kinase assay (KA) and immunoblotting (IB), respec-(Figure 1C), little effect on IFN mRNA induction was
tively.
observed in Ikka2/2 MEFs (Figure 4C). However, a large
decrease in induction of IFNa1 and IFNb mRNAs by
dsRNA was observed in Ikkb2/2 MEFs (Figure 4D).
JNK and IKK Required for Interferon Induction
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Figure 4. Defective IFN mRNA Induction by
dsRNA in Cells Lacking PKR, JNK2, or IKKb
(A) Wt (Pkr1/1) and Pkr2/2 3T3s were left un-
treated or incubated with dsRNA (100 mg/ml)
for 1 hr. After washing with PBS, the cells
were incubated in complete medium for 3 hr,
after which total RNA was extracted. IFNa1,
IFNb, and GAPDH mRNA levels were deter-
mined by Northern blot analysis.
(B) Wt (Jnk21/1) and Jnk22/2 MEFs and 3T3
fibroblasts were left untreated or treated with
dsRNA as above. IFNa1, IFNb, and GAPDH
mRNA levels were determined as described
above.
(C) Ikka1/1 and Ikka2/2 MEFs or (D) Ikkb1/1
and Ikkb2/2 MEFs were treated as above and
analyzed for induction of IFN mRNA.
We also compared induction of IFN mRNA in response or replication, because VSV genomic RNA accumulated
with slightly faster kinetics in both Ikkb2/2 and Jnk22/2to VSV infection of the different fibroblast cultures. In-
duction of IFNa1 and IFNb mRNA was normal in Ikka2/2 cells than in wt cells. A considerable reduction in IFN
gene induction in response to VSV infection also wascells (Figure 5A). However, a considerable reduction in
IFN gene induction was observed in Ikkb2/2 cells (Figure observed in Pkr2/2 cells (Figure 5D).
In addition to type I IFNs, treatment of cells with5B). A partial decrease in both IFNa1 and IFNb mRNA
induction was also observed in Jnk22/2 fibroblasts (Fig- dsRNA results in induction of cytokines such as TNFa,
IL-1, IL-6, and IL-12 (Gendelman et al., 1990; Verdijk eture 5C). The reduction in IFN induction in both Ikkb2/2
and Jnk22/2 cells was not due to a defect in viral infection al., 1999). We found that JNK2- and IKKb-deficient cells
Figure 5. Defective IFN mRNA Induction in
Response to VSV Infection in PKR-, IKK-, and
JNK-Deficient Cells
(A) Ikka1/1 and Ikka2/2 MEFs were infected
with VSV at moi 5 10 or mock infected. At
the indicated times post infection (7 hr for
mock infected cells), total RNA was extracted
and analyzed for expression of IFNa1, IFNb,
and GAPDH mRNAs. VSV replication (Rep)
was monitored by hybridization to a probe
for the L gene.
(B) Ikkb1/1 and Ikkb2/2 MEFs, (C) Jnk21/1 and
Jnk22/2 MEFs; and (D) Pkr1/1 and Pkr2/2 3T3s




and 7E). While both promoters were highly responsive
to VSV in wt cells, very little activation of either promoter
was observed in either Jnk22/2 or Ikkb2/2 cells, thus
confirming the results of the RNA analysis.
Discussion
Role of JNK in the Antiviral Response
Viral infection or dsRNA treatment results in induction
of type I IFNs (IFNa1 and IFNb), which in turn confer an
antiviral state (Sen and Lengyel, 1992). Initially, it was
assumed that the only signaling molecule activated in
response to virus or synthetic dsRNA, a mimic of early
products of viral infections, is the dsRNA-dependent
protein kinase PKR. Not only is PKR activity and expres-
sion induced by dsRNA and viral infections (Clemens
and Elia, 1997; Williams, 1997), but its overexpression
protects cultured cells from vaccinia virus (Lee and Es-
teban, 1993) and encephalomyocarditis virus but not
from VSV (Meurs et al., 1992). In addition, several viruses
have evolved different strategies to inhibit PKR activity
and thereby became IFN resistant (Katze, 1992; Taylor
et al., 1999). The use of certain protein kinase inhibitors,
which are not particularly specific to PKR, suggested
that PKR is essential for IFN induction (Zinn et al., 1988).
It was therefore surprising that PKR-deficient mice gen-Figure 6. Defective Cytokine Induction in JNK2- and IKKb-Deficient
erated by gene targeting exhibited nearly normal induc-Fibroblasts
tion of type I IFNs in response to viral infection or dsRNAMEFs from wild-type, Jnk22/2, and Ikkb2/2 mice were treated with
either IL-1 (20 ng/ml), LPS (10 mg/ml), or dsRNA (100 mg/ml) or left (Yang et al., 1995) and normal antiviral responses (Yang
untreated. After 4 hr, total RNA was isolated and expression of IL-6, et al., 1995; Abraham et al., 1999). The results, however,
IL-12, IFNb, and GAPDH determined by Northern blot hybridization. turn out to depend on the type of virus used, and PKR-
deficient mice were recently found to be highly sensitive
to VSV infection (N. Sonnenberg, personal communica-
were also defective in induction of IL-6 and IL-12 by tion). MEFs derived from PKR-deficient mice exhibit de-
dsRNA, IL-1, or LPS (Figure 6). As expected, IL-1 and fective IFN gene induction, in response to either virus
LPS did not induce INFb expression in these cells. or dsRNA. This defect can be rescued by ªprimingº with
low levels of type I IFN (Yang et al., 1995). It was therefore
suggested that the response of Pkr2/2 mice to dsRNA isJNK2 Is Required for IFNa and IFNb
Promoter Activation caused by low-level IFN production due to background
exposure to environmental pathogens. Nevertheless, itTo determine whether the defect in IFN mRNA induc-
tion in Jnk22/2 cells occurs at the level of IFN gene tran- was also suggested that there must be another, PKR-
independent activation pathway involved in IFN genescription, we transfected established wt, Jnk12/2, and
Jnk22/2 fibroblasts with a luciferase (LUC) reporter induction (Yang et al., 1995; Abraham et al., 1999). Our
results identify one such signaling pathway as the onedriven by the IFNb promoter (truncated at 2125; Yone-
yama et al., 1998). After normalization for transfection that leads to JNK activation. We demonstrate that JNK
activity is potently stimulated by dsRNA or infectionefficiency (which was quite similar in the different cell
lines), the IFNb promoter was approximately 4-fold less with the RNA virus VSV, in a manner that is entirely
independent of PKR. Furthermore, JNK activity is notactive in Jnk22/2 cells, although a residual response to
dsRNA was still observed (Figure 7A). In Jnk12/2 cells, responsive to overexpression of PKR. Using MEFs and
immortalized (3T3) fibroblast lines derived from JNK2-the response was similar to that in wt fibroblasts. Similar
results were obtained using an IFNb-CAT reporter (trun- deficient mice (Sabapathy et al., 1999), we provide ge-
netic evidence that JNK activation is required for optimalcated at 2110; Figure 7B). Induction of the IFNb pro-
moter by dsRNA in Jnk22/2 cells, and to a lesser extent induction of IFNa1 and IFNb transcription.
The discovery of this physiological function for thebasal promoter activity, were potentiated by cotransfec-
tion of a JNK2 vector (Figure 7C). By contrast, cotrans- JNK pathway fits nicely with previous analysis of the
IFNb promoter, which contains four positive regulatoryfection of a nonactivatable JNK2 mutant, JNK2 (APF)
(Kallunki et al., 1994), reduced basal IFNb promoter ac- domains (PRDs) required for its induction by virus or
dsRNA (Du et al., 1993; Thanos and Maniatis, 1995).tivity and completely prevented its induction. This mu-
tant most likely acts as a dominant-negative inhibitor of PRD IV is recognized by a heterodimer of c-Jun and
ATF2, as well as the structural protein HMGI(Y) (Du et al.,the residual JNK activity present in Jnk22/2 cells.
We also compared the activation of the IFNa1 (trun- 1993). c-Jun and ATF2, which belong to the AP-1/ATF
family of transcription factors, are the most extensivelycated at -140; Yoneyama et al., 1998) and IFNb promot-
ers by VSV in wt, Jnk22/2, and Ikkb2/2 cells (Figures 7D characterized JNK substrates (Karin, 1995). In both
JNK and IKK Required for Interferon Induction
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Figure 7. JNK2 Is Involved in Control of IFNb
Gene Transcription
(A) Wt, Jnk12/2, and Jnk22/2 3T3 cells were
transiently transfected with an 2125IFNb-
Luc reporter (125-Luc; Yoneyama et al.,
1998). After 36 hr, the cells were left untreated
or incubated with dsRNA (100 mg/ml) for 4
hr. The cells were collected and lysed, and
luciferase activity was determined. The re-
sults shown are averages of two independent
experiments normalized for transfection effi-
ciency determined by cotransfection of a
SV40-LacZ reporter and measurement of
b-galactosidase activity.
(B) Wt and Jnk22/2 3T3 cells were cotrans-
fected with -110IFNb-CAT (Wathelet et al., 1998)
and SV40-LacZ reporters. After 48 hr, the cells
were treated or not with dsRNA for 4 hr. The
cells were collected and lysed, and CAT and
b-galactosidase activities were determined.
Shown are the results of a typical CAT assay
and the relative fold-induction of CAT activity
normalized to b-galactosidase expression.
(C) Jnk22/2 3T3 cells were cotransfected with
2125IFNb-Luc and SV40-LacZ reporters and
either empty, HA-JNK2, or HA-JNK2 (APF) ex-
pression vectors. After 24 hr, the cells were
treated or not with dsRNA, and cell lysates
were prepared 4 hr later. Luciferase and
b-galactosidase activities were determined.
Shown are average luciferase activities from
two independent experiments normalized to
b-galactosidase levels.
(D) Wt, Ikkb2/2, and Jnk22/2 cells were transfected with 2140IFNa1-Luc (La-Luc; Yoneyama et al. 1998) and SV40-LacZ reporters. After 46
hr, the cells were either mock infected or infected with VSV at m.o.i 5 10. After 9 more hr, lysates were prepared and luciferase and
b-galactosidase activities determined as above.
(E) Similar experiment to the one above except that an 2125IFNb-Luc reporter was used.
cases, JNK-mediated phosphorylation of specific sites points. After several hours, residual NF-kB activation
can be observed in Pkr2/2 cells. This delayed responsewithin their activation domains enhances their ability to
activate transcription (Smeal et al., 1991; Hibi et al., could, in principle, be due to the priming effect dis-
cussed above or to activation of a PKR-independent1993; DeÂ rijard et al., 1994; Gupta et al., 1995). Our pres-
ent results explain how viral infection results in stimula- pathway, possibly the one that leads to JNK activation.
As NF-kB binds to PRDII of the IFNb promoter (Lenardotion of c-Jun:ATF2 activity.
The inability of Pkr2/2 MEFs to respond to dsRNA with et al., 1989; Visvanathan and Goodbourn, 1989), its de-
fective activation can explain the defect in IFNb induc-IFN gene induction can be remediated by priming with
small amounts of IFN (Yang et al., 1995). We therefore tion in Pkr2/2 cells. However, Pkr2/2 cells also exhibit a
defect in IFNa1 induction (Yang et al., 1995; Figures 4examined whether JNK activation by dsRNA or virus
may be a secondary response that depends on low-level and 5), despite the absence of NF-kB binding sites in
the proximal IFNa1 promoter (MacDonald et al., 1990).IFN induction, which may occur even in the absence
of PKR. However, JNK activation was not inhibited by The similar reduction in both IFNa1 and IFNb mRNA
induction and promoter activation in Ikkb2/2 MEFspretreatment with the protein synthesis inhibitor cyclo-
heximide and treatment of 3T3 or HEK293 cells with strongly suggests that NF-kB is, nonetheless, involved
IFNa or IFNg did not activate JNK (W.-M. C. and M. K., in IFNa1 induction. Although the IFNa1 promoter may
unpublished data). In addition, the loss of IKKb, which lack NF-kB binding sites, NF-kB may still be recruited to
causes a substantial reduction in IFN induction (Figures this promoter via an interaction with other transcription
4 and 5), has no effect on JNK activation (Figure 1). factors, such as AP-1 (Stein et al., 1993).
Thus, it is unlikely that JNK activation is a consequence The defect in NF-kB activation in PKR-deficient cells is
of IFN induction. due to their inability to rapidly activate the IKK complex.
Previous work has demonstrated that the IKKg/NEMO
regulatory subunit is required for NF-kB activation byRole of IKK and Other Signaling Pathways
dsRNA (Yamaoka et al., 1998). Here, we show that IKKIn addition to the defect in IFN gene induction, Pkr2/2
catalytic activity is stimulated by either dsRNA or viralMEFs can not mount a normal NF-kB activation re-
infection and that this response is largely dependent onsponse to dsRNA (Yang et al., 1995). We show that this
PKR. As previously shown for TNFa and IL-1 (Delhasedefect can be extended to VSV as an inducer. However,
et al., 1999; Li et al., 1999, 1999; Tanaka et al., 1999),with both dsRNA and VSV, the defect in NF-kB activation
is not absolute and is mostly restricted to early time the stimulation of IKK activity by dsRNA or VSV and
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consequently activation of NF-kB are dependent on AP-1 and NF-kB transcription factors in vertebrates (Ip
and Davis, 1998; Hoffmann et al., 1999). The role of NF-IKKb, but not IKKa. In cotransfection experiments, we
find that PKR efficiently stimulates phosphorylation of kB in the control of innate immune and inflammatory
responses in mammals is well recognized (Baldwin,IKKb at the same activating phosphoacceptor sites used
by the TNFa pathway (W.-M. C. and M. K., unpublished 1996; May and Ghosh, 1998). Recent results have estab-
lished the role of the JNK pathway in induction of severaldata). As high levels of catalytically inactive PKR can
result in IKK activation, both in vivo and in vitro, we important cytokines, including IL-2, IL-4, and IFNg, in
response to T cell activation (Dong et al., 1998; Yang etsurmise that PKR activates IKK via protein±protein inter-
action that stimulates the autophosphorylation of IKKb al., 1998; Sabapathy et al., 1999). It is also well estab-
lished that JNK and IKK are activated by LPS or the(Delhase and Karin, 1999), rather than by direct phos-
phorylation of IKKb. In support of this interpretation of proinflammatory cytokines. The results presented here
demonstrate that JNK and IKK are also activated inthe results shown in Figure 3, we obtained evidence
suggesting a physical interaction between PKR and IKK response to viral infection and dsRNA. Furthermore,
JNK2 and IKKb are essential elements of the innate(W.-M. C. and M. K., unpublished data). Most likely,
the catalytic activity of PKR is required for its initial response to viral infection or dsRNA, required for induc-
tion of type I IFNs and other cytokines, including IL-6activation that eventually results in its transcription in-
duction and elevated expression (Clemens and Elia, and IL-12. Whereas IFNs inhibit virus replication, IL-6
and IL-12, which are also induced by bacterial infec-1997; Williams, 1997).
Another viral- and dsRNA-responsive transcription tions, elicit cytotoxic responses needed for elimination
of intracellular pathogens. Thus, JNK and IKK serve asfactor involved in type I IFN gene induction is IRF3 or
IRF7 (Juang et al., 1998; Schafer et al., 1998; Wathelet universal activators of innate immune responses to bac-
teria and viruses.et al., 1998; Yoneyama et al., 1998). These closely related
members of the IRF family bind to PRDI and PRDIII of Our results may also explain how dsRNA can induce
costimulation of T cells (Hoffmann et al., 1999) andthe IFNb promoter and to related elements in the IFNa1
promoter. In response to viral infection, IRF3 is phos- upregulate expression of numerous cytokines (Gendel-
man et al., 1990; Verdijk et al., 1999). Thus, JNK andphorylated at a cluster of serines near its C terminus,
and this modification induces its nuclear entry and inter- IKK, being responsive to LPS and dsRNA, provide an
important link between innate and adaptive immunity. Inaction with the coactivator CBP/p300 (Juang et al., 1998;
Yoneyama et al., 1998). The protein kinase responsible this context, it is appealing to draw an analogy between
dsRNA and LPS. While the first serves as a genericfor IRF3 phosphorylation has not been identified, but
examination of the identified C-terminal phosphoaccep- signal for viral infection, the second serves as a generic
signal indicating infection by Gram-negative bacteria.tor sites suggests that they are not a target for PKR,
JNK, or IKK. Indeed, we have not been able to detect LPS and other byproducts of bacterial infections are
recognized by the Toll family of pattern recognition re-efficient phosphorylation of the C-terminal portion of
IRF3 by JNK or IKK (W.-M. C. and M. K., unpublished ceptors (Medzhitov and Janeway, 1997; Hoffmann et
al., 1999). It is possible that dsRNA, whose chemicaldata).
Induction of type I IFN in most cell types is a specific properties resemble those of LPS (being a negatively
charged polysaccharide), may also activate membersresponse to viral infection that does not occur following
cell stimulation with TNFa (Thanos and Maniatis, 1995), of this rapidly growing family.
IL-1, or LPS (Figure 6). However, TNFa, IL-1, and LPS
Experimental Proceduresare potent activators of the IKK and JNK pathways,
which lead to stimulation of NF-kB and AP-1 activities.
PlasmidsTherefore, other transcription factors, most likely IRF3
Expression vectors encoding HA-tagged wt and mutant IKKa and
and/or IRF7, that interact with IFN gene promoters, must IKKb, HA-tagged JNK1 and JNK2, wt PKR, and catalytically inactive
be responsible for this response specificity. By contrast, PKR (296R) were previously described (Kallunki et al., 1994; Kumar
et al., 1997; Zandi et al., 1997). Reporter plasmids containing IFNbactivation of AP-1 and NF-kB may be sufficient for induc-
and IFNa1 promoter were kindly provided by Drs. T. Maniatis (-110tion of other cytokines, such as IL-6 and IL-12, whose
IFN-CAT; Thanos and Maniatis, 1995) and T. Fujita (-125-Luc-; -140promoters contain binding sites for these factors
La-Luc; Yoneyama et al., 1998). IFNa1 and IFNb cDNA plasmids(Sanceau et al., 1995).
were kindly provided by Dr. Y.-L. Yang.
Cell Culture, Transfection, dsRNA Treatment,The Role of JNK and IKK in Innate
and Viral InfectionImmune Responses
Cells were cultured in DMEM supplemented with 10% FBS andInfection with bacterial, fungal, and viral pathogens re-
antibiotics. Cells were transfected using Lipofectamine (Gibco) orsults in activation of innate immune responses, which
Superfect (Qiagen), according to manufacturers' recommendations.
provide the first line of defense against infection and Cells were washed twice with PBS before incubating with dsRNA
alert the adaptive immune system to the presence of in serum-free medium containing dextran sulfate (5 mg/ml). VSV
strain T1026R1 (obtained from Dr. J. Lucas-Lenard, U. of Connecti-pathogens (Medzhitov and Janeway, 1997). Innate im-
cut, Storrs) was used in all experiments, as it is a good IFN inducermunity has appeared early in evolution, preceding the
(Boulares et al., 1996). High-titer virus stocks were prepared in BHKappearance of adaptive immunity, which is unique to
cells from a single plaque isolate. Mouse cell monolayers grown tovertebrates (Hoffmann et al., 1999). Analysis of innate
80%±90% confluency on 6 cm dishes were infected at an moi of
immune responses to bacteria and fungi in Drosophila 10 (based on pfu titer determined on BHK cells). Virus was absorbed
have implicated the involvement of signaling pathways at room temperature for 30 min in 0.5 ml of medium. Incubation at
378C was initiated concurrent with addition of 3.5 ml of mediumthat are highly similar to those that lead to activation of
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(time 0). In some experiments, resulting virus titers were determined Boulares, A.H., Ferran, M.C., and Lucaslenard, J. (1996). NF-kappa-B
activation is delayed in mouse L929 cells infected with interferonat about 24 hr post infection (p.i.) by plaque assay on BHK cells.
suppressing, but not inducing, vesicular stomatitis strains. Virology
218, 71±80.Immunoprecipitation, Kinase, Electrophoretic Mobility,
Clemens, M.J., and Elia, A. (1997). The double-stranded RNA-depen-and Reporter Assays
dent protein kinase PKR: structure and function. J. Interferon Cyto-Lysates were prepared and incubated with antibody at 48C over-
kine Res. 17, 503±524.night. Immunoprecipitates were washed and used either for kinase
assays or for immunoblotting. Immunecomplex kinase assays, im- Darnell, J.E., Kerr, I.M., and Stark, G.R. (1994). Jak-STAT pathways
munoblot analysis, and electrophoretic mobility shift assay (EMSA) and transcriptional activation in response to IFNs and other extracel-
were carried out as described (Zandi et al., 1997; Rothwarf et al., lular signaling proteins. Science 264, 1415±1421.
1998). Wt and catalytically inactive PKR were expressed and purified Delhase, M., and Karin, M. (1999). The IkB kinase: a master regulator
from E. coli, while IKKb was expressed and purified from Sf9 cells of NF-kB, innate immunity and epidermal differentiation. Cold Spring
(Zandi et al., 1998). The proteins were coincubated in kinase buffer Harb. Symp. Quant. Biol. 64, in press.
in the presence of ATP and then the IkB kinase activity of IKKb was
Delhase, M., Hayakawa, M., Chen, Y., and Karin, M. (1999). Positiveassayed by standard procedures. CAT and Luciferase assays were
and negative regulation of IkB kinase activity through IKKb subunit
performed as described (Wathelet et al., 1998).
phosphorylation. Science 284, 309±313.
DeÂ rijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin,RNA Analysis
M., and Davis, R.J. (1994). JNK1: a protein kinase stimulated by UV
For Northern blot analysis, 10 mg of total RNA per lane was fraction-
light and Ha-Ras that binds and phosphorylates the c-Jun activation
ated on a 1% denaturing agarose gel (Yang et al., 1995). Northern
domain. Cell 76, 1025±1037.
blots were hybridized with random-primed 32P-labeled probes for
DiDonato, J.A., Hayakawa, M., Rothwarf, D.M., Zandi, E., and Karin,glyceraldehyde-3-phosphate dehydrogenase (GAPDH), IFNa1, or
M. (1997). A cytokine-responsive IkB kinase that activates the tran-IFNb (Yang et al., 1995). Radioactivity was quantified using a phos-
scription factor NF-kB. Nature 388, 548±554.phoimager (Molecular Dynamics), and all values were normalized
Dong, C., Yang, D.D., Wysk, M., Whitmarsh, A.J., Davis, R.J., andrelative to the GAPDH value in the same lane.
Flavell, R.A. (1998). Defective T cell differentiation in the absenceTo analyze viral RNA expression, medium was removed from in-
of Jnk1. Science 282, 2092±2095.fected cells, and monolayers were washed twice with cold PBS
before lysis in 0.2 ml of 0.05 M Tris-Cl (pH 7.6), 0.2 M NaCl, 3 mM Du, W., Thanos, D., and Maniatis, T. (1993). Mechanisms of transcrip-
EDTA, 0.5% NP-40, and 10% glycerol. Nuclei were removed by tional synergism between distinct virus-inducible enhancer ele-
centrifugation at 2,000 3 g for 5 min at 48C. Half of each extract ments. Cell 74, 887±898.
was immediately processed for analysis of total cytoplasmic RNA Gendelman, H.E., Friedman, R.M., Joe, S., Baca, L.M., Turpin, J.A.,
(viral and cellular), while the other half was first treated with micro- Dveksler, G., Meltzer, M.S., and Dieffenbach, C. (1990). A selective
coccal nuclease (Sigma, 1.5 units, 15±30 min at 378C in the presence defect of interferon alpha production in human immunodeficiency
of 10 mM CaCl2) before RNA extraction. The latter protocol is used virus-infected monocytes. J. Exp. Med. 172, 1433±1442.
to assay for VSV genomic replication, which yields encapsidated Gupta, S., Campbell, D., DeÂ rijard, B., and Davis, R.J. (1995). Tran-
products resistant to nuclease digestion. RNA purification by pro- scription factor ATF2: regulation by the JNK signal transduction
teinase K and phenol-chloroform as well as Northern blot analysis pathway. Science 267, 389±393.
of viral RNA were carried out as described (Spadafora et al., 1996).
Hibi, M., Lin, A., Smeal, T., Minden, A., and Karin, M. (1993). Identifi-Viral genome replication was probed with 32P-labeled T7 transcript
cation of an oncoprotein-responsive and UV-responsive protein ki-containing nucleotides 286 to 2559 of L gene (plus strand).
nase that binds and potentiates the c-Jun activation domain. Genes
Dev. 7, 2135±2148.
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